Let-7 is an important downstream effector of Lin28, which had been reported to regulate self-renewal and tumorigenicity of breast cancer cells [22], and antagonizing let-7 using antisense oligonucleotide inhibitors enhances reprogramming of mouse fibroblasts to iPSCs [37]. Here, LIN28A is linked to breast cancer.